New data released at The Menopause Society’s annual meeting reveals a decline in the number of people opting for hormone replacement therapy (HRT) for menopause, despite its proven effectiveness in alleviating symptoms such as hot flashes and night sweats. A study by the Mayo Clinic, soon to be published in Menopause, analyzed medical and pharmacy claims of individuals aged 40 and above enrolled in commercial insurance or Medicare Advantage over 16 years. The research showed a decrease in HRT usage from 4.6% in 2007 to 1.8% in 2023. This trend suggests that fewer menopausal individuals are choosing HRT as a treatment option.
The decline in HRT use can be attributed to the results of the Women’s Health Initiative (WHI) study in 2002, which linked a specific combination of estrogen and progestin to increased risks of breast cancer, heart attacks, stroke, and blood clots. Subsequent studies have revealed that the benefits of HRT often outweigh the risks, especially for younger individuals and those closer to menopause onset. Despite this, the negative impact of the WHI study continues to influence decision-making around HRT.
While there are some risks associated with HRT, such as an increased risk of breast cancer, heart attack, and stroke for certain individuals, newer studies have shown that the risk varies among individuals and depends on other health factors. For most individuals under 60 and within 10 years of menopause onset, the benefits of HRT typically outweigh the risks. Lifestyle factors such as maintaining a healthy weight, regular exercise, and monitoring blood pressure and cholesterol levels can help mitigate potential complications.
HRT is an effective treatment option for managing menopausal symptoms, including hot flashes, night sweats, vaginal dryness, bone health, and mood swings. Additionally, starting HRT within six years of menopause onset may reduce the risk of heart disease. Choosing to undergo HRT is a personal decision that should be made in consultation with a healthcare provider who can assess individual health factors and determine the most suitable form of HRT.
In conclusion, the conversation around menopause treatment is evolving, with a growing acknowledgment of the benefits of HRT and the need for better education and support for those considering this treatment option. Self-advocacy and seeking out qualified healthcare providers who are knowledgeable about menopause treatment are essential steps in ensuring optimal care and symptom management during this life transition.
